PRPH

PRPH

USD

ProPhase Labs Inc. Common Stock (DE)

$0.283-0.005 (-1.840%)

Preço em tempo real

Healthcare
Diagnostics & Research
Estados Unidos

Gráfico de preços

Loading Chart...

Métricas-chave

Métricas de mercado
Fundamentos da empresa
Estatísticas de negociação

Métricas de mercado

Abertura

$0.288

Máximo

$0.288

Mínimo

$0.257

Volume

0.76M

Fundamentos da empresa

Capitalização de mercado

11.7M

Setor

Diagnostics & Research

País

United States

Estatísticas de negociação

Volume médio

6.45M

Bolsa de valores

NCM

Moeda

USD

Faixa de 52 semanas

Mínimo $0.22Atual $0.283Máximo $0.93

Relatório de análise de IA

Última atualização: 10/11/2025
Gerado por IAFonte de dados: Yahoo Finance, Bloomberg, SEC

PRPH (ProPhase Labs Inc.) Market Analysis: Unlocking Value Despite Mixed Signals

News Sentiment Overview

Recent headlines highlight major validation for ProPhase Labs

Notícias relacionadas

GlobeNewswire

ProPhase Labs Announces Publication of BE-Smart Esophageal Cancer Study in the Official Journal of the American College of Gastroenterology

Peer-Reviewed Study Conducted in Collaboration with Mayo Clinic Demonstrates 100% Sensitivity and Strong Predictive Power for Esophageal Cancer Progression Early Access Programs and Physician Onboarding Initiatives

Ver mais
ProPhase Labs Announces Publication of BE-Smart Esophageal Cancer Study in the Official Journal of the American College of Gastroenterology
GlobeNewswire

ProPhase Labs to Present at the 2025 ThinkEquity Conference

UNIONDALE, NY, Oct. 24, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ:PRPH) (the "Company" or "ProPhase"), a next generation biotech, genomics, and consumer products company, today announced that it will be

Ver mais
ProPhase Labs to Present at the 2025 ThinkEquity Conference
GlobeNewswire

ProPhase Labs Announces Study Validating BE-Smart Esophageal Cancer Test Accepted by Journal of Clinical Gastroenterology and Hepatology

Study Acceptance Supports and Provides the Catalyst for Upcoming Commercial Rollout and Revenue-Generating Potential UNIONDALE, NY, Oct. 22, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ:PRPH) ("ProPhase" or the

Ver mais
ProPhase Labs Announces Study Validating BE-Smart Esophageal Cancer Test Accepted by Journal of Clinical Gastroenterology and Hepatology

Previsão de IABeta

Recomendação de IA

Altista

Atualizado em: 10/11/2025, 09:37

BaixistaNeutroAltista

58.2% Confiança

Risco e negociação

Nível de risco3/5
Risco médio
Adequado para
Valor
Guia de negociação

Ponto de entrada

$0.27

Tomar lucro

$0.33

Parar perda

$0.25

Fatores-chave

PDI 35.5 está acima do MDI 28.2 com ADX 11.3, sugerindo tendência de alta
MACD 0.0019 está abaixo da linha de sinal 0.0023, indicando um crossover de baixa

Mantenha-se atualizado

Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.